Skip to Content

Join the 'Akovaz' group to help and get support from people like you.

Akovaz News

Health Tip: Feeling Under the Weather?

Posted 7 hours ago by Drugs.com

-- Even if you're sick with a cold or the flu, don't neglect your teeth, the American Dental Association reminds us. The group offers these suggestions: Don't ever share your toothbrush, especially if you've been sick. It's usually not necessary to get a new toothbrush after you've been sick, unless you have a weak immune system or it's time to toss your brush anyway. If you're using cough drops, opt for sugar free. If you vomit, don't brush your teeth immediately afterward. Instead, swish with water or diluted mouthwash. Drink plenty of water to avoid dry mouth, which could harm teeth. Read more

Related support groups: Nausea/Vomiting, Vomiting, Influenza, Cold Symptoms, Pseudoephedrine, Flonase, Phenylephrine, Sore Throat, Nasonex, Afrin, Nasacort, Ephedrine, Veramyst, Omnaris, Oxymetazoline, Azelastine, Viral Infection, Astelin, Phenylpropanolamine, Nasacort AQ

Health Tip: Trying to Unclog That Stuffy Nose?

Posted 12 Dec 2016 by Drugs.com

-- Over-the-counter decongestants can spell relief from a stuffy nose, but it's important to use them properly to avoid side effects. The American Academy of Family Physicians advises: Read and follow package instructions. Do not take more than the recommended dose. Check with your doctor to make sure an OTC decongestant is safe to take with your other meds. Don't take more than one decongestant at a time. Call your doctor or pharmacist if you have questions. Read more

Related support groups: Influenza, Nasal Congestion, Cold Symptoms, Pseudoephedrine, Phenylephrine, Cough and Nasal Congestion, Afrin, Ephedrine, Oxymetazoline, Azelastine, Astelin, Phenylpropanolamine, Otrivin, Dymista, 4-Way, Tetrahydrozoline, SudoGest, Twice-A-Day, Olopatadine, Dexatrim

Flamel Technologies Receives FDA Approval of Akovaz (ephedrine sulfate) for Surgical Hypotension

Posted 3 May 2016 by Drugs.com

LYON, FRANCE--(Marketwired - May 2, 2016) - Flamel Technologies (NASDAQ: FLML) today announced that the U.S. Food and Drug Administration (FDA) has approved the Company's New Drug Application (NDA) for Akovaz™ (ephedrine sulfate), a drug administered parenterally as a pressor agent to address clinically important hypotension in surgical settings. Flamel obtained NDA approval for Akovaz as scheduled on April 29 and is the first to receive approval from the FDA for ephedrine sulfate. Flamel expects to launch Akovaz during the third quarter 2016 in a strength of 50 mg/mL. "We are very excited to receive FDA approval for Akovaz, the third product from our Éclat portfolio, and in line with the PDUFA date expectations. Revenue expectations associated with this product were included in our previously issued 2016 revenue guidance of $110 - $130 million. Our Éclat portfolio of products, which in ... Read more

Related support groups: Surgery, Anesthesia, Hypotension, Ephedrine, Akovaz

Ask a Question

Further Information

Related Condition Support Groups

Hypotension

Akovaz Patient Information at Drugs.com